Tags

TEVA

אקמול
Teva shifts popular painkiller production to Germany, updates packaging
Acamol, a household name in Israel, will now be made in Ulm; while prices remain steady, capsule counts will change; company says Israeli staff will focus on complex drugs and no jobs will be cut
Navit Zomer | 08.05.25
מטה טבע
Trump’s drug price cuts hit Teva at a tough time
Israeli pharmaceutical giant recently announced plans to cut 8% of its global workforce and U.S. push for lower drug prices could trigger further layoffs
Sophie Shulman | 05.13.25
ריצ'רד פרנסיס, נשיא ומנכ"ל טבע, במפגש העיתונאים
Hundreds of Israeli workers could be affected by Teva layoffs
Analysis: The pharmaceutical giant has announced an 8% cut in its workforce to improve efficiency;  About 300 employees in Israel are expected to be laid off. While investors are pleased with the promise of reaching a 30% operating profit, employees may find that this is just the first 'big step' in a series of cuts 
Sophie Shulman, Calcalist | 05.08.25
Teva Pharmaceutical Industries
Teva to lay off 2,900 employees by 2027 - about 8% of workforce
Company will embark on a large-scale layoff process over the next two years and will also cut expenses to increase operating profit; Revenue in the first quarter was $3.89 billion, slightly below forecasts, but net income came in at 52 cents per share, above expectations; Its main drug, Austedo, generated higher-than-expected revenue
Sophie Shulman, Calcalist | 05.07.25
Teva shares jump by 26% on Wall Street as its most promising drug shows exceptional trial results
Duvakitug, a treatment for colitis and Crohn's disease, surpassed expectations and positions Teva to compete in the $28 billion global inflammatory bowel disease market       
Sophie Shulman | 12.17.24
ריצ'רד פרנסיס, נשיא ומנכ"ל טבע, במפגש העיתונאים
Teva Q2 results stronger than expected
The pharmaceutical company reports revenue of $4.2 billion and earnings of 61 cents per share. Austedo, Teva's strongest drug, designed to treat Dyskinesia, grew by 32% and generated revenues of $407 million 
Sophie Shulman, Calcalist | 08.01.24
טבע
Teva to pay US millions in price-fixing settlement
Israeli pharmaceutical company set to pay $225 million in several installments over the next five years after court finds it and other companies responsible for rising drug prices - by up to 1000%
Sophie Shulman/Calcalist | 08.22.23
Israel's Teva agrees to pay $126 mln to US hospitals over opioids
Pharmaceutical says it has been sued by about 500 U.S. hospitals and other healthcare providers over sale of brand-name fentanyl-based drug Fentora
08.03.23
Teva office building
Teva to pay $193 million to Nevada in opioid case
Pharmaceutical company's spokesperson confirms settlement following claims Teva's practices in the U.S. led to widespread opioid addiction; payment plan will last from 2024 up to 2043
Reuters | 06.08.23
Previous Articles
Hot Tags
Today
This Week
This Month
9/11Abbas KamelaccidentagricultureAIAliyahAmine AyoubAncient EgyptAntiquesAntisemitism
Hot Tags
Today
This Week
This Month
9/11Abbas KamelaccidentagricultureAIAliyahAmine AyoubAncient EgyptAntiquesAntisemitism
Related Tags
RussiaUkraineUnited KingdomRussia-Ukraine warBoycottStock MarketmedicineTel Aviv Stock ExchangeLayoffsstocks
""